|
| Press Releases |
|
 |
|
| Friday, June 13, 2025 |
|
|
Jacobson Pharma Announces FY2025 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing, and sale of essential medicines and specialty drugs, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2025 ("FY2025" or the "Reporting Period"). more info >> |
|
|
雅各臣公佈二零二五財年全年業績 持續經營業務溢利飈升43.1％至3.0億港元 |
| 從事基礎藥物及專科藥物研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633.HK）今天公佈公司及其附屬公司（統稱「集團」）截至二零二五年三月三十一日止年度（「二零二五財年」或「報告期」）的全年業績。 more info >> |
|
|
雅各臣公布二零二五财年全年业绩 持续经营业务溢利飙升43.1％至3.0亿港元 |
| 从事基础药物及专科药物研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633.HK）今天公布公司及其附属公司（统称「集团」）截至二零二五年三月三十一日止年度（「二零二五财年」或「报告期」）的全年业绩。 more info >> |
|
| Friday, November 22, 2024 |
|
|
Jacobson Pharma Announces FY2025 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines and specialty drugs, today announced the interim results of the Company and its subsidiaries (collectively, the "Group") for the six months ended 30 September 2024 (the "Reporting Period"). more info >> |
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2% |
| 從事基礎藥物及專科藥物研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633.HK）今天公佈公司及其附屬公司（統稱「集團」）於截至二零二四年九月三十日止六個月（「報告期」）的中期業績。 more info >> |
|
| Friday, November 25, 2022 |
|
|
雅各臣公布二零二三财年中期业绩 |
| 从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 （「 雅各臣 」 或 「 公司 」；股份代号 2633.HK ) 今天公布公司及其附属公司（统称「集团」）于截至二零二二年九月三十日止年度（「报告期」）的中期业绩。 more info >> |
|
|
雅各臣公佈二零二三財年中期業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 （「 雅各臣 」 或 「 公司 」；股份代號 2633.HK ) 今天公佈公司及其附屬公司（統稱「集團」）於截至二零二二年九月三十日止年度（「報告期」）的中期業績。 more info >> |
|
|
Jacobson Pharma Announces FY2023 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
| Wednesday, June 29, 2022 |
|
|
雅各臣公布二零二二财年全年业绩 |
从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 （「 雅各臣 」或「 公司 」； 股份代号： 2633.HK )今天公布公司及其附属公司（统称「集团」）于截至二零二二年三月三十一日止年度（「二零二二财年」或「报告期」）的全年业绩。
more info >> |
|
|
雅各臣公佈二零二二財年全年業績 |
| 從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 （「 雅各臣 」或「 公司 」； 股份代號： 2633.HK )今天公佈公司及其附屬公司（統稱「集團」）於截至二零二二年三月三十一日止年度（「二零二二財年」或「報告期」）的全年業績。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
'Hong Kong Cinema @ BUSAN 2025' successfully held, Promoting Hong Kong film production, enhancing international exchange and cooperation
Sept 23, 2025 13:59 HKT/SGT
|
|
|
May Raise Funds via Rights Issue to Drive AI Digital Humans, RWA Framework, and Strategic Digital Asset Acquisitions
Sept 23, 2025 13:55 HKT/SGT
|
|
|
大洋集团未来或通过供股集资 用于发展AI数字人、RWA架构及购买战略性数字资产
Sept 23, 2025 13:55 HKT/SGT
|
|
|
大洋集團未來或通過供股集資 用於發展AI數字人、RWA架構及購買戰略性數字資產
Sept 23, 2025 13:55 HKT/SGT
|
|
|
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
Sept 23, 2025 13:15: JST
|
|
|
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
Sept 23, 2025 12:15 HKT/SGT
|
|
|
康哲藥業就用於破傷風被動免疫和狂犬病被動免疫的兩款創新生物製劑達成合作
Sept 23, 2025 11:16 HKT/SGT
|
|
|
康哲药业就用于破伤风被动免疫和狂犬病被动免疫的两款创新生物制剂达成合作
Sept 23, 2025 11:16 HKT/SGT
|
|
|
GreenTech Launches 'WateRobot AI Agent' Pioneering a New Path for Industrial Water Savings and Efficiency with AI
Sept 23, 2025 11:06 HKT/SGT
|
|
|
IFBH發力功能飲品賽道 多元佈局加速打造「第二增長曲線」
Sept 23, 2025 10:13 HKT/SGT
|
|
|
IFBH发力功能饮品赛道 多元布局加速打造第二增长曲线
Sept 23, 2025 10:13 HKT/SGT
|
|
|
Nissin Foods Secured Contracts for Its Land Use Rights in Zhuhai
Sept 23, 2025 08:46 HKT/SGT
|
|
|
日清食品簽訂珠海土地使用權合同
Sept 23, 2025 08:46 HKT/SGT
|
|
|
日清食品签订珠海土地使用权合同
Sept 23, 2025 08:46 HKT/SGT
|
|
|
Kincora Secures Full Rights to the Mongolian Copper-Gold Portfolio
Sept 22, 2025 21:39 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
